NCT02366273

Brief Summary

Patients with psoriasis will be evaluated. The investigators will collect personal history, concomitant diseases and in particular the presence of type 2 diabetes mellitus, impaired fasting glucose and impaired glucose tollerance. The aim of the study will be to evaluate if there is a correlation among inflammation, insulin-resistance and psoriasis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
425

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2015

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

February 11, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 19, 2015

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2018

Completed
Last Updated

May 24, 2022

Status Verified

May 1, 2022

Enrollment Period

3.1 years

First QC Date

February 11, 2015

Last Update Submit

May 21, 2022

Conditions

DiabetesPsoriasis

Keywords

DiabetesPsoriasisInflammationInsulin-resistance

Outcome Measures

Primary Outcomes (1)

  • Evaluation of correlation between diabetes and psoriasis

    3 years

Interventions

PASI and HOMA indexOTHER

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with psoriasis

You may qualify if:

  • patients with psoriasis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Policlinico San Matteo Foundation

Pavia, 27100, Italy

Location

MeSH Terms

Conditions

Diabetes MellitusPsoriasisInflammationInsulin Resistance

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesSkin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsHyperinsulinism

Study Officials

  • Giuseppe Derosa, MD, PhD, FESC

    University of Pavia - IRCCS Policlinico San Matteo Foundation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

February 11, 2015

First Posted

February 19, 2015

Study Start

February 1, 2015

Primary Completion

February 28, 2018

Study Completion

June 30, 2018

Last Updated

May 24, 2022

Record last verified: 2022-05

Locations

IT(1)